Highlights from Day 2: addressing challenges in CAR-T therapy for ALL, AML, CLL & more…

Просмотров: 1 | Время: 14:22 | Голосов: +1 +1 | Скачать

Скачать клип Highlights from Day 2: addressing challenges in CAR-T therapy for ALL, AML, CLL & more…